Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05435339
Title A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Genmab
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Yale University New Haven Connecticut 06510 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Clinica Universidad de Navarra Pamplona Navarra Spain Details
Hospital Universitari Vall d'Hebron Barcelona Spain Details
Centro Integral Oncologico Clara Campal Madrid Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field